Carbon Monoxide Research Group, LDS Hospital, Utah in reply to Scheinkestel et al. and Emerson: The role of hyperbaric oxygen in carbon monoxide poisoning

EMA - Emergency Medicine Australasia

Volumn 16, Issue 5-6, 2004, Pages 394-399

  Weaver, Lindell K ^a,b,d   Hopkins, Ramona O ^a,e   Chan, Karen J ^c,e   Thomas, Frank ^a,b,e   Churchill, Susan K ^a,f   Elliott, C Gregory ^a,b,g   Morris, Alan ^a,b,h  

^a LDS HOSPITAL   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^c BRIGHAM YOUNG UNIVERSITY   (United States)

^d Hyperbaric Medicine   (United States)

^e Respiratory ICU   (United States)

^f Hyperbaric Medicine

^g Pulmonary Division   (United States)

^h Department of Research ^*

Author keywords

Carbon monoxide; Clinical trial; Cognitive; Neuropsychological; Poisoning

Indexed keywords

CARBON MONOXIDE; CARBOXYHEMOGLOBIN;

BAROTRAUMA; BLOOD SAMPLING; CARBON MONOXIDE INTOXICATION; CLINICAL TRIAL; COGNITION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DAILY LIFE ACTIVITY; HUMAN; HYPERBARIC OXYGEN; LONG TERM EXPOSURE; MAJOR CLINICAL STUDY; NEUROLOGIC EXAMINATION; NEUROPSYCHOLOGICAL TEST; NYSTAGMUS; PATIENT SELECTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; REVIEW; SELF REPORT; STATISTICAL ANALYSIS;

EID: 9244247596     PISSN: 17426731     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1742-6723.2004.00666.x     Document Type: Review

References (41)

1. Scheinkestel CD, Jones K, Myles PS, Cooper J, Miller IL, Tuxen DV. Where to now with carbon monoxide poisoning? Emerg. Med. Australas. 2004; 16: 151-4.
2. Weaver LK, Hopkins RO, Chan KJ et al. Hyperbaric oxygen for acute carbon monoxide poisoning. N. Engl. J. Med. 2002; 347: 1057-67.
3. Weaver LK, Chan KJ, Hopkins RO, Churchill S. Risk factors in acute carbon monoxide poisoning (Abstract). Undersea and Hyper. Med. 2004 (in press); Available at URL: www.uhms.org.
4. Weaver LK, Hopkins RO, Churchill S, Chan KJ. Randomized trial carbon monoxide poisoned patients compared to non-randomized patients (Abstract). Undersea Hyper. Med. 2003; 30: 244-5.
5. Scheinkestel CD, Bailey M, Myles PS et al. Hyperbaric or normobaric oxygen for acute carbon monoxide poisoning: a randomized controlled clinical trial. Med. J. Aust. 1999; 170: 203-10.
6. Emerson G. The dilemma of managing carbon monoxide poisoning. Emerg. Med. Australas. 2004; 16: 101-2.
7. Ilano AL, Raffin TA. Management of carbon monoxide poisoning. Chest 1990; 7: 165-9.
8. Martzke JS, Murkin JM, Baird DL, Adams SJ, Lok P. Perioperative predictors of neuropsychological outcome 3 years after coronary artery bypass surgery. Anesth. Analg. 1996; 82: SCA1-SCA130.
9. Mitchell SJ, Pellett O, Gorman DF. Cerebral protection by lidocaine during cardiac operations. Ann. Thorac. Surg. 1999; 67: 1117-24.
10. Wang DW, Xinmin W, Li Jun, Feng X, Xiaoying L, Meijin M. The effect of lidocaine on early postoperative cognitive dysfunction after coronary artery bypass surgery. Anesth. Analg. 2002; 95: 1134-41.
11. Denburg SD, Stewart KE, Hart LE, Denburg JA. How 'soft' are soft neurological signs? The relationship of subjective neuropsychiatric complaints to cognitive function in systemic lupus erythematosus. J. Rheumatol. 2003; 30: 1006-10.
12. Dik MG, Jonker C, Comijs HC et al. Memory complaints and APOE-epsilon 4 accelerate cognitive decline in cognitively normal elderly. Neurology 2001; 57: 2217-22.
13. Donnell WJ. The language of medical case histories. Ann. Intern. Med. 1997; 127: 1045-8.
14. Spilker B. Guide to Clinical Trials. New York: Lippincott-Raven, 1996.
15. Wechsler D. Wechsler Adult Intelligence Scale. (Revised) New York: Psychologcial Corporation, 1981.
16. Reitan R, Wolfson D. The Halstead-Reitan Neuropsycholgocal Test Battery: Theory and Clinical Interpretation. Tucson, AZ: Neuropsychology Press, 1985.
17. Denman S. Denman neuropsychological memory scale. South Carolina: Denman, 1984.
18. Heaton RK, Grant I, Matthews CG. Comprehensive Norms for an Expanded Halstead-Reitan Battery: Demographic Corrections, Research Findings and Clinical Applications. Odessa, FL: Psychological Assesment Resources, Inc., 1991.
19. Newman SP. Analysis and interpretation of neuropsychologic tests in cardiac surgery. Ann. Thorac. Surg. 1995; 59: 1351-5.
20. Murkin JM, Stump DA, Blumenthal JA, McKhann G. Defining dysfunction: Group means versus incidence analysis - A statement of consensus. Ann. Thorac. Surg. 1997; 64: 904-5.
21. Yesavage JA, Brink TL, Rose TL et al. Development and validation of a geriatric depression screening scale: a preliminary report. J. Psychiatr. Res. 1982; 17: 37-49.
22. Katz S, Downs TD, Cash HR, Grotz RC. Progress in development of the index of ADL. Gerontologist 1970; 10: 20-30.
23. Stewart AL, Hays RD, Ware JE Jr. The MOS short-form general health survey. Reliability and validity in a patient population. Med. Care 1988; 26: 724-35.
24. Plafki C, Peters P, Almeling M, Welslau W, Busch R. Complications and side effects of hyperbaric oxygen therapy. Aviat. Space Environ. Med. 2000; 71: 119-24.
25. Bohan JS. Benefit of hyperbaric oxygen therapy for acute carbon monoxide poisoning. J. Watch Emerg. Med. 2002; 6: 1.
26. Brett AS. Hyperbaric oxygen for acute carbon monoxide poisoning. J. Watch 2002; 22: 165.
27. Pitts S. Three hyperbaric oxygen treatments reduced cognitive sequelae of acute carbon monoxide poisoning. ACP J. Club 2003; 138: 67.
28. Raphael JC, Chadda K, Driheme A et al. Comparaison des effets de l'oxygénothérapie normobare et hyperbare dans l'intoxication oxygcarbonee aiguë d'origine domestique. Deux essays thérapeutiques. Réan. Urg. 2001; 10 (Suppl. 1): 108S [Abstract in French].
29. Thorn SR, Taber RL, Mendiguren II, Clark JM, Hardy KR, Fisher AB. Delayed neuropsychologic sequelae after carbon monoxide poisoning: prevention by treatment with hyperbaric oxygen. Ann. Emerg. Med. 1995; 25: 474-80.
30. Thorn SR. Functional inhibition of leukocyte B2 integrins by hyperbaric oxygen in carbon monoxide-mediated brain injury in rats. Toxicol. Appl. Pharmacol. 1993; 123: 248-56.
31. Brown SD, Piantadosi CA. Reversal of carbon monoxide-cytochrome c oxidase binding by hyperbaric oxygen in vivo. Adv. Exp. Med. Biol. 1989; 248: 747-54.
32. Brown SD, Piantadosi CA. Recovery of energy metabolism in rat brain after carbon monoxide hypoxia. J. Clin. Invest. 1992; 89: 666-72.
33. Cardellach F, Miro O, Casademont J. Hyperbaric oxygen for acute carbon monoxide poisoning (letter). N. Engl. J. Med. 2003; 348: 559.
34. Cronjé FJ, Carraway MS, Freiberger JJ, Piantadosi CA. Dissociation of tissue and blood levels after exceptional carbon monoxide exposure in rats. Undersea and Hyper Med. 2004; (in press) [Available at URL: www.uhms.org.]
35. Weaver LK, Haberstock D, Churchill S. Transport of carbon monoxide-poisoned patients enrolled in a randomized clinical trial (Abstract). Undersea Hyper. Med. 2003; 30: 243.
36. Kurz X, Scuvee-Moreau J, Vernooij-Dassen M, Dresse A. Cognitive impairment, dementia and quality of life in patients and caregivers. Acta Neurol. Belg. 2003; 103: 24-34.
37. Bullinger M, Axouvi P, Brooks N et al. Quality of life in patients with traumatic brain injury-basic issues, assessment and recommendations. Restor. Neurol. Neurosci. 2002; 20: 111-24.
38. Griffith HR, Belue K, Sicola A et al. Impaired financial abilities in mild cognitive impairment: a direct assessment approach. Neurology 2003; 60: 449-57.
39. Withaar FK, Brouwer WH, van Zomeren AH. Fitness to drive in older drivers with cognitive impairment. J. Int. Neuropsychol. Soc. 2000; 6: 480-90.
40. Rockwood K, Brown M, Merry H, Sketris I, Fisk J. Societal costs of vascular cognitive impairment in older adults. Stroke 2002; 33: 1605-9.
41. Runciman WW, Gorman DF. Carbon monoxide poisoning. From old dogma to new uncertainties. Med. J. Aust. 1993; 158: 439-40.